 |
||||||||
|
|
The most common form of management in current practice is the use of one dysfunction erectile vitamin of the oral PDE-5 inhibitors. If one agent does not work at its maximum dosage, another agent should be tried. Trying these medications 3-4 times is sometimes necessary before concluding that the therapy is ineffective. Men who have a vascular-leak phenomenon may need a constriction device placed at the base of the penis to maintain the erection, which may be effective by itself or in combination with a PDE-5 inhibitor. In selected cases, combination therapy with one of the PDE-5 inhibitors plus Yohimbine, MUSE, or intracavernosal injections can be tried. Although some men have taken 2 different PDE-5 inhibitors simultaneously, no evidence suggests a benefit and the risk of significant adverse effects is greatly enhanced. dysfunction erectile new
If none of these therapies is satisfactory to the patient and his partner, a discussion regarding the relative merits and adverse effects associated with penile implants can be introduced. Some data indicate an additional benefit in some men who have an implant but also take a PDE-5 inhibitor. Sexual stimulation and sensation is enhanced.
Psychogenic impotence is relatively uncommon. It is characterized objectively by the presence of good nocturnal and morning erections and negative findings from all other tests. During the interview, a history of highly variable dysfunction erectile meds erections that can be totally absent one day but virtually normal the next suggests a psychogenic cause. Virtually 100% of men with severe depression have ED. Sildenafil (Viagra) works well for psychogenic ED; other treatment modalities are also effective because the tissues, nerves, hormone levels, and vasculature are normal. The authors usually recommend a full psychological evaluation in these patients so that the underlying etiology can be identified and treated appropriately rather than just treating the symptom of ED. Therefore, the authors defer treatment of the patient's ED until he has begun psychological testing and therapy for the underlying problem. dysfunction erectile home
Vacuum devices
erectile dysfunction drugs As a relatively inexpensive method for producing an erection, vacuum devices to draw blood into the penis have been used for many years. These are plastic cylinders that are placed over the penis. Air is pumped out, causing a partial vacuum. After an erection is obtained, a constricting band is placed at the base of the penis. This technique is effective in 60-90% of patients and maintains the erection for up to 30 minutes.
These devices are generally safe, but hematomas, petechia, and ecchymosis have been reported. Other adverse effects include pain, lower penile erectile dysfunction causes temperature, numbness, absent or painful ejaculation, and pulling of scrotal tissue into the cylinder. Many of these problems can be alleviated by proper selection of the tension rings and cylinders. The devices are very reliable and seem to work better with increased use and practice. They can be operated and used quickly with experience but still tend to be less romantic than other therapeutic options.
One drawback to the use of these external vacuum devices is the need to assemble the equipment and the difficulty in transporting it. Many patients lose interest in using the device because of the preparations that are erectile dysfunction Atlanta necessary, the lack of easy transportability, the inability to hide the tension ring, and the relative lack of spontaneity. Approximately half the men who use a vacuum device obtain good erections, but only half of these men consistently use the device for a long period.
Sildenafil (Viagra)
Sildenafil is the first oral agent to be well documented as an effective form of treatment for men experiencing ED. Since its introduction in March, 1998, no erectile dysfunction vacuums other therapy for ED has achieved such prominent public recognition. Of the 250,000 American physicians who have written prescriptions for sildenafil, 14% have been written by urologists and 82% by nonurologists.
Controlled clinical trials in selected populations of men with ED have demonstrated the efficacy of sildenafil in helping men achieve and maintain erections. The efficacy of sildenafil was demonstrated in 21 randomized, double-blind, placebo-controlled studies of up to 6 months' duration involving more than 3000 male subjects aged 20-87 years.
Sildenafil is a potent inhibitor of PDE-5, the enzyme that acts in the corpora to break down cGMP. This action is mediated by the secondary neurotransmitter NO, which is primarily responsible for smooth muscle relaxation within the new drugs for erectile dysfunction corpora cavernosa. The inhibition of PDE-5 slows the degradation of NO, which enhances its effect. This permits the development of an improved and sustainable erection.
Sildenafil has been demonstrated to improve erectile function in diabetic patients, hypertensive patients, post–transurethral resection of the prostrate patients, radical prostatectomy patients following radiation therapy for prostate cancer, geriatric patients, spinal cord injury patients, and depression patients. As many as 66-90% of patients with ED secondary to brachytherapy or external beam radiation therapy for prostate cancer have significant improvements in erectile function.
The long-term efficacy of sildenafil has been shown in a 48-month, open- causes of erectile dysfunction label, noncontrolled, flexible-dose study. One year following the initiation of therapy, efficacy and satisfaction continued to be significantly improved.
Safety concerns and adverse effects have been studied carefully. The most common adverse effects are headaches and upper GI distress. These are not usually severe and are self-limited when the drug is stopped. Sildenafil is a mild inhibitor of phosphodiesterase type 6, which is found in the retina. This inhibition is manifested by a blue haze at the periphery of the field of vision but is not dangerous. Very few patients have stopped taking sildenafil because of this effect.
The cardiac effects associated with sildenafil have been studied extensively. erectile dysfunction clinics Sildenafil is absolutely contraindicated in patients taking nitrates such as nitroglycerine or isosorbide. Patients with serious cardiac disease, with exertional angina, or taking multiple antihypertensive medications are advised to seek the advice of a cardiologist before beginning therapy with sildenafil. A number of studies examining the cardiac effects of sildenafil have conclusively shown that there are no adverse consequences.
In the original clinical trials involving more than 3000 male subjects, the laser therapy for erectile dysfunction incidence of myocardial infarction and myocardial ischemia was not significantly different between those who took a placebo and those who took sildenafil. The same was true when postural hypotension was evaluated. Exertion associated with sexual activity has been documented to increase the chances of ischemic events and myocardial infarction. Men with ischemic heart disease who do not take sildenafil have as penial erectile dysfunction much as a 2-fold increase in cardiac events compared with healthy men.
Sildenafil is available in 3 doses: 25 mg, 50 mg, and 100 mg. The starting dose depends on the clinical situation. A man in his fifth decade of life with mild sexual dysfunction that is probably related to psychological factors can start on the 25-mg dose. Men with moderate-to-severe ED can begin at the 50-mg dose, and, after testing the effect of the drug on at least 3 occasions, the dose can be modified. Men with severe ED can start on the 100-mg dose; these men are not likely to achieve a satisfactory response, but they should penile erectile dysfunction make 3-4 attempts to take the drug before starting another form of therapy.
Sildenafil should be taken on an empty stomach approximately 45-60 minutes prior to sexual intercourse. This agent is not taken daily. Sexual stimulation is necessary to produce an erection. An increased sensitivity to obtain erections can last 24 hours.
laser treatment of erectile dysfunction physician who use it Vardenafil (Levitra), which is available in 5-mg, 10-mg, and 20-mg doses, became available in 2003. These lower doses are effective because this agent has a 9-fold increase in selectivity for the specific receptor responsible for NO release in the penis.
Yohimbine
This oral agent has been available for many years. It has both a central and a peripheral effect. Its efficacy has been questioned because even in properly conducted, well-controlled studies, yohimbine is only slightly better than placebo. A renewed interest in this agent has occurred, particularly when combined with sildenafil or some of the other oral agents.
erectile dysfunction symptoms Yohimbine is a safe agent with few known adverse effects. It is administered daily in a dose of 5.4 mg (1 tab) 3 times/d.
l-arginine and erectile dysfunction Apomorphine (Uprima)
Apomorphine is a sublingual agent that is not yet approved by the US Food and Drug Administration. Apomorphine has a central effect on the hypothalamus. It is a D1/D2 dopamine receptor agonist from the apomorphine (nonopiate) drug class. This agent has been shown to specifically activate c-fos gene expression in the paraventricular and supraoptic nuclei of the hypothalamus in animal models. These areas are known to be involved with penile erections.
erectile dysfunction corrections The administration of apomorphine by subcutaneous, oral, and intranasal routes results in variable effects on erectile function and moderate-to-severe adverse effects, primarily nausea and vomiting. A new slow-release sublingual formulation has demonstrated erectile effects with a significant reduction in adverse effects.
Of 977 subjects who received double-blind medication, 774 (79.2%) completed the course of treatment. Several doses were used, but patients in all of the apomorphine dose groups reported erections firm enough for herbal remedies for erectile dysfunction penetration more often than those taking placebo (P <.01). When separated according to dose, firm erections were reported by 45% versus 35% of the control group with the 2-mg dose. The 4-mg dose elicited positive responses in 55%, compared with 36% in the placebo group. With the 6-mg dose, 60% reported positive responses, compared with 32% in control subjects. Adverse events occurring in 10% or smoking and erectile dysfunction more of the patients in any group were nausea, sweating, dizziness, somnolence, vomiting, yawning, and asthenia. Most of these were considered mild to moderate in severity. Nausea was the most common adverse effect, which was found to be dose-related and reducible with repeated exposure to the drug.
Phentolamine (Vasomax)
This agent is an alpha-receptor blocker that is not yet approved by the US Food and Drug Administration but has undergone limited clinical testing.
Detumescence is influenced by alpha-adrenergic tone. Alpha-1 receptors predominate in the trabecular smooth muscle cells of the corpora cavernosa, alpha-2 receptors are the predominant receptors in the cavernosal arteries, fixing erectile dysfunction and both alpha-1 and alpha-2 receptors are present in the circumflex and deep cavernosal veins.
Two placebo-controlled trials reported effectiveness in 42% and 32% of patients taking 50 mg compared with 9% and 13% in the control group, respectively. The erections occurred in 20-30 minutes. The drug was well tolerated, with mild-to-moderate adverse effects, usually headaches or lightheadedness, occurring in less than 10% of patients.
Androgens
Men who present with diminished libido and ED may be found to have low serum testosterone levels. Hormone replacement may be of benefit to those laser treatment of erectile dysfunction with severe hypogonadism and possibly as adjunctive therapy when other treatments are unsuccessful by themselves. Libido and an overall sense of well-being are likely to improve when serum testosterone levels are restored to the reference range.
Replacement androgens are available in oral, injectable, and transdermal preparations. Oral therapy is the least effective and the most likely to be associated with hepatotoxicity, even though this is a small risk. Parenteral testing erectile dysfunction therapy is most likely to restore androgen levels to the reference range, but this therapy requires periodic injections, usually every 2 weeks, to sustain an effective level. Skin patches deliver a sustained dose and are generally accepted by patients. An androgen cream is now available for daily topical use for male hypogonadism. medication for erectile dysfunction
The use of exogenous androgens suppresses any natural androgen production. Elevating serum androgen levels has the potential to stimulate prostate growth and may increase the risk of activating a latent cancer. These effects are hypothetical and have not been tested in a clinical setting. Periodic prostate examinations, including digital rectal examinations, prostate-specific antigen determinations, and blood counts (ie, CBC counts), are recommended in all patients receiving supplemental androgens. Obtaining a testosterone chiropractic treatment erectile dysfunction level while on therapy is also suggested to optimize the dosage.
Injection therapy
While many substances are touted as aphrodisiacs, the modern age of pharmacotherapy began in 1993 when the injection of papaverine, an alpha-receptor blocker that produces vasodilatation, was shown to produce erections when injected directly into the corpora cavernosa. Soon afterwards, erectile dysfunction and urologist + new haven other vasodilators, such as PGE1 and phentolamine (Regitine), were demonstrated to be effective either as single agents or in combination.
Self-injection of these agents has been of enormous benefit because they represent the most effective way to achieve erections in a wide variety of men who otherwise would be unable to achieve adequately rigid erections.
If the vasculature within the corpora cavernosa is healthy, the use of injectable agents is almost always effective. Instruct patients how to perform cialis erectile dysfunction the injections, and the urologist must determine the appropriate dose. The dosage is adjusted to achieve an erection with adequate rigidity for no more than 90 minutes. Up to 40 mcg of alprostadil can be used. An abnormal finding after biothesiometry testing has been suggested as an indicator of possible heightened sensitivity to intracavernosal injections, but this is unproved.
Alprostadil, a synthetic PGE1, is the most commonly used single agent used for intracavernosal injections. When used in combination with papaverine and Regitine, the mixture is called Trimix and it has roughly twice the efficacy of alprostadil alone. In one study of 683 men, 94% reported having erections erectile dysfunction research suitable for penetration after alprostadil injections. The main adverse effects are a painful erection, priapism, or the development of scarring at the site of the injection. Alprostadil is now available in a gel and a patch. There are no long-term studies comparing the efficacy and acceptance of these new forms of therapy compared to the oral agents.
Intraurethral therapy (MUSE)
Alprostadil, PGE1, has been formulated into a small suppository that can be inserted into the urethra. In a selected group of men, the agent was effective in 65%. This agent may be effective in men with vascular disease, diabetes, urologist use of laser for erectile dysfunction in ca and status post prostate surgery. This is a useful agent for men who do not want to use self-injections or for men in whom oral medications have failed. It has been successfully used together with sildenafil in cases in which each agent alone failed. Few adverse effects occur, and the most common is a painful erection, which occurs in less than 10% of the patients. erectile dysfunction surgery
